Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Clinical trial NCT06929468 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06929468
Sponsor: Simon Jäger
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Ototoxic Hearing Loss Ototoxicity, Drug-Induced Cisplatin-induced Hearing Loss Cisplatin Ototoxicity Head and Neck Cancer Dizzyness Inner Ear Hearing Loss Vestibular Disease Squamous Cell Carcinoma of the Head and Neck Deafness Hearing Loss

Start date: 2025-07-01
Primary completion: 2027-06-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.